23andMe Holding Co.

ME

US90138Q1085

Healthcare Facilities & Services

Delayed Nasdaq Other stock markets 15:55:04 2024-05-31 EDT			5-day change	1st Jan Change
0.5432 ^USD	-2.69%		+8.42%	-39.10%

05-23	Earnings Flash (ME) 23ANDME Reports Q4 Revenue $64M, vs. Street Est of $61.5M	MT
05-23	23andMe Q4 Loss Widens, Revenue Decreases	MT

VG Acquisition Corp. has Changed its Name to 23andMe Holding Co

June 11, 2021 at 05:28 pm

VG Acquisition Corp. changed its name to 23andMe Holding Co.

Latest news about 23andMe Holding Co.

Earnings Flash (ME) 23ANDME Reports Q4 Revenue $64M, vs. Street Est of $61.5M	05-23	MT
23andMe Q4 Loss Widens, Revenue Decreases	05-23	MT
Transcript : 23andMe Holding Co., Q4 2024 Earnings Call, May 23, 2024	05-23
23andMe Holding Co. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-23	CI
23andMe Holding Co. Reports Unaudited Consolidated Goodwill Impairment for the Fourth Quarter Ended March 31, 2024	05-23	CI
Alibaba Cuts ADS Holdings by 60% in Q1	05-15	MT
Sector Update: Health Care Stocks Rise in Late Afternoon Trading	05-14	MT
Sector Update: Health Care Stocks Ease in Tuesday Afternoon Trading	05-14	MT
23andMe Unit Offers Petros Pharmaceuticals' Impotency Medication	05-14	MT
23andMe Holding Co. to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology Annual Meeting	04-24	CI
Petros, Lemonaid Health Collaborate to Expand Stendra Availability	04-23	MT
Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup	04-18	DJ
US Equity Markets Close Mixed Thursday	04-18	MT
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading	04-18	MT
Sector Update: Health Care Stocks Ease in Afternoon Trading	04-18	MT
Sector Update: Health Care	04-18	MT
News Highlights : Top Company News of the Day - Thursday at 1 PM ET	04-18	DJ
Top Midday Stories: Taiwan Semiconductor Manufacturing, Blackstone, Elevance Health, D.R. Horton, Infosys and Marsh & McLennan Report Earnings; Tesla's Musk Says Laid-Off Employees Received "Incorrectly Low" Severance; 23andME CEO Mulls Taking Company Private; Northrop Grumman Working with SpaceX on Spy Satellite	04-18	MT
News Highlights : Top Company News of the Day - Thursday at 11 AM ET	04-18	DJ
23andMe CEO Mulls Plan to Take Company Private	04-18	MT
23andMe CEO Mulls Plan to Take Company Private	04-18	MT
23andMe CEO Considering Taking Company Private	04-18	MT
North American Morning Briefing : Stock Futures Rise After TSMC Earnings	04-18	DJ
News Highlights : Top Company News of the Day - Thursday at 5 AM ET	04-18	DJ
News Highlights : Top Company News of the Day - Thursday at 1 AM ET	04-18	DJ

23andMe Holding Co. is a genetics-led consumer healthcare and therapeutics company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including information on customersâ genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. The Therapeutics business segment focuses on the use of genetic insights from databases of genetic and phenotypic information to develop novel therapies to improve patientsâ lives. The Therapeutics segment consists of out-licensing of intellectual property associated with identified drug targets and expenses related to therapeutic product candidates.

Sector

Healthcare Facilities & Services

Calendar

2024-06-01 - American Society of Clinical Oncology Meeting - Abstract: 4129

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

INTERVIEW - Anne Wojcicki, CEO of 23andMe: partnership with Amazon and cancer treatment results

July 13, 2023 at 02:26 pm

More Strategies

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.5582 USD

Average target price

1.315 USD

Spread / Average Target

+135.58%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
23ANDME HOLDING CO.	-39.10%	274M
SONIC HEALTHCARE LIMITED	-24.16%	7.66B
RADNET, INC.	+68.90%	4.35B
DR. LAL PATHLABS LIMITED	+2.72%	2.62B
SYNLAB AG	-2.98%	2.53B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-46.17%	2.21B
NEOGENOMICS, INC.	-15.33%	1.79B
FLEURY S.A.	-22.78%	1.48B
METROPOLIS HEALTHCARE LIMITED	+13.62%	1.18B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-43.81%	1.13B

Medical & Diagnostic Laboratories

23andMe Holding Co.

Equities

ME

US90138Q1085

Healthcare Facilities & Services

VG Acquisition Corp. has Changed its Name to 23andMe Holding Co

Latest news about 23andMe Holding Co.

Chart 23andMe Holding Co.

Company Profile

Income Statement Evolution

Analysis / Opinion

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical & Diagnostic Laboratories